We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Analysis of the immune-inflammatory indices for patients with metastatic hormone-sensitive and castration-resistant prostate cancer

    Background

    Inflammation plays a pivotal role in the progression of prostate cancer (PCa). Several immune-inflammatory indices, including neutrophil to...

    Zhipeng Wang, Haoyang Liu, ... Hao Zeng in BMC Cancer
    Article Open access 09 July 2024
  2. A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)

    Background

    Therapeutic options for early-stage hepatocellular carcinoma (HCC) in individual patients can be limited by tumor and location, liver...

    Alan Wigg, Jonathan Tibballs, ... David Pryor in BMC Cancer
    Article Open access 08 July 2024
  3. Stromal lymphocytes are associated with upgrade of B3 breast lesions

    Various histopathological, clinical and imaging parameters have been evaluated to identify a subset of women diagnosed with lesions with uncertain...

    Tan**a Kader, Elena Provenzano, ... Kylie L. Gorringe in Breast Cancer Research
    Article Open access 08 July 2024
  4. Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer

    The protein Bcl-2, well-known for its anti-apoptotic properties, has been implicated in cancer pathogenesis. Identifying the primary gene responsible...

    Noor Bahadar, Sher Bahadar, ... Qingjia Sun in Breast Cancer Research
    Article Open access 08 July 2024
  5. Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN

    The randomized, phase 2 GRIFFIN study (NCT02874742) evaluated daratumumab plus lenalidomide/bortezomib/dexamethasone (D-RVd) in transplant-eligible...

    Ajai Chari, Jonathan L. Kaufman, ... Paul G. Richardson in Blood Cancer Journal
    Article Open access 08 July 2024
  6. Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

    In patients with relapsed DLBCL in complete remission (CR), autologous hematopoietic cell transplantation (auto-HCT) and CAR-T therapy are both...

    Mazyar Shadman, Kwang W. Ahn, ... Mehdi Hamadani in Blood Cancer Journal
    Article Open access 08 July 2024
  7. Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis

    Background

    Non-small cell lung cancer (NSCLC) is the primary reason for cancer-related deaths globally. Tertiary lymphoid structure (TLS) is an...

    Luyuan Ma, Rongyang Li, ... Hui Tian in BMC Cancer
    Article Open access 08 July 2024
  8. Electrical excitability of cancer cells—CELEX model updated

    The normal functioning of every cell in the body depends on its bioelectric properties and many diseases are caused by genetic and/or epigenetic...

    Mustafa B. A. Djamgoz in Cancer and Metastasis Reviews
    Article Open access 08 July 2024
  9. Subclinical dose irradiation triggers human breast cancer migration via mitochondrial reactive oxygen species

    Background

    Despite technological advances in radiotherapy, cancer cells at the tumor margin and in diffusive infiltrates can receive subcytotoxic...

    Justin D. Rondeau, Justine A. Van de Velde, ... Pierre Sonveaux in Cancer & Metabolism
    Article Open access 08 July 2024
  10. Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma

    Background

    Despite a multimodal approach including surgery, chemo- and radiotherapy, the 5-year event-free survival rate for rhabdomyosarcoma (RMS),...

    Simona Camero, Luisa Milazzo, ... Francesca Megiorni in BMC Cancer
    Article Open access 08 July 2024
  11. Development and validation of an automated Tomotherapy planning method for cervical cancer

    Purpose

    This study aimed to develop an automated Tomotherapy (TOMO) planning method for cervical cancer treatment, and to validate its feasibility and...

    Feiru Han, Yi Xue, ... Shengpeng Jiang in Radiation Oncology
    Article Open access 08 July 2024
  12. Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma

    Background

    Distinguishing benign from malignant pancreaticobiliary disease is challenging because of the absence of reliable biomarkers. Circulating...

    Daniel S.K. Liu, Jisce R. Puik, ... Adam E. Frampton in Journal of Experimental & Clinical Cancer Research
    Article Open access 08 July 2024
  13. Selective anti-tumor activity of glutathione-responsive abasic site trap** agent in anaplastic thyroid carcinoma

    Anaplastic thyroid carcinoma (ATC) is a rare but highly aggressive thyroid cancer with poor prognosis. Killing cancer cells by inducing DNA damage or...

    **yan Chai, Mengxue Su, ... Zhaowei Meng in BMC Cancer
    Article Open access 08 July 2024
  14. Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patients

    Background

    Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive cancer characterized by an immunosuppressive microenvironment. Patients from...

    Nnenna Elebo, Ebtesam A. Abdel-Shafy, ... Ekene Emmanuel Nweke in BMC Cancer
    Article Open access 07 July 2024
  15. Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning

    Background and aims

    The recurrence of papillary thyroid carcinoma (PTC) is not unusual and associated with risk of death. This study is aimed to...

    Binqian Zhou, Jianxin Liu, ... Qin Zhou in BMC Cancer
    Article Open access 07 July 2024
  16. Melanoma risk, tumour stage, and melanoma-specific mortality in individuals with diabetes: a systematic review and meta-analysis

    Background

    Cancer has become the leading diabetes-related cause of death in high-income countries, and more knowledge is needed to clarify the impact...

    Jens Ejrnæs Tønder, Marie Louise Bønnelykke-Behrndtz, ... Martin Sollie in BMC Cancer
    Article Open access 07 July 2024
  17. KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer

    Purpose

    There is mounting evidence that patients with liver cancer can benefit from Immune checkpoint inhibitors. However, due to the high cost and...

    Sihui Zhu, Yuncheng **, ... Jie Shen in BMC Cancer
    Article Open access 07 July 2024
Did you find what you were looking for? Share feedback.